Literature DB >> 2156895

The adenosine/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively.

B N Cronstein1, L Daguma, D Nichols, A J Hutchison, M Williams.   

Abstract

Occupancy of specific receptors on neutrophils by adenosine or its analogues diminishes the stimulated release of toxic oxygen metabolites from neutrophils, while paradoxically promoting chemotaxis. We now report evidence that two distinct adenosine receptors are found on neutrophils (presumably the A1 and A2 receptors of other cell types). These adenosine receptors modulate chemotaxis and O2- generation, respectively. N6-Cyclopentyladenosine (CPA), a selective A1 agonist, promoted neutrophil chemotaxis to the chemoattractant FMLP as well as or better than 5'N-ethylcarboxamidoadenosine (NECA). In contrast, CPA did not inhibit O2- generation stimulated by FMLP. Pertussis toxin completely abolished promotion of chemotaxis by CPA but enhanced inhibition by NECA of O2- generation. Disruption of microtubules by colchicine or vinblastine also abrogated the enhancement by NECA of chemotaxis whereas these agents did not markedly interfere with inhibition by NECA of O2- generation. FMLP receptors, once they have bound ligand, shift to a high affinity state and become associated with the cytoskeleton. NECA significantly increased association of [3H]FMLP with cytoskeletal preparations as it inhibited O2-. Disruption of microtubules did not prevent NECA from increasing association of [3H]FMLP with cytoskeletal preparations. Additionally, CPA (A1 agonist) did not increase binding of [3H]FMLP to the cytoskeleton as well as NECA (A2 agonist). These studies indicate that occupancy of one class of adenosine receptors (A1) promotes chemotaxis by a mechanism requiring intact microtubules and G proteins whereas engagement of a second class of receptors (A2) inhibits O2- generation. Signalling via A2 receptors is independent of microtubules, insensitive to pertussis toxin and is associated with binding of [3H]FMLP to cytoskeletal preparations.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2156895      PMCID: PMC296546          DOI: 10.1172/JCI114547

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  52 in total

1.  Simultaneous measurement of stimulus-induced changes in cytoplasmic Ca2+ and in membrane potential of human neutrophils.

Authors:  K G Lazzari; P J Proto; E R Simons
Journal:  J Biol Chem       Date:  1986-07-25       Impact factor: 5.157

2.  Engagement of adenosine receptors inhibits hydrogen peroxide (H2O2-) release by activated human neutrophils.

Authors:  B N Cronstein; S M Kubersky; G Weissmann; R Hirschhorn
Journal:  Clin Immunol Immunopathol       Date:  1987-01

3.  Cytoplasmic pH regulation in activated human neutrophils: effects of adenosine and pertussis toxin on Na+/H+ exchange and metabolic acidification.

Authors:  S Grinstein; W Furuya
Journal:  Biochim Biophys Acta       Date:  1986-12-19

Review 4.  Model for leukocyte regulation by chemoattractant receptors: roles of a guanine nucleotide regulatory protein and polyphosphoinositide metabolism.

Authors:  R Snyderman; C D Smith; M W Verghese
Journal:  J Leukoc Biol       Date:  1986-12       Impact factor: 4.962

5.  Receptor-cytoskeleton interactions and membrane traffic may regulate chemoattractant-induced superoxide production in human granulocytes.

Authors:  A J Jesaitis; J O Tolley; R A Allen
Journal:  J Biol Chem       Date:  1986-10-15       Impact factor: 5.157

6.  The effects of adenosine agonists on human neutrophil function.

Authors:  D J Schrier; K M Imre
Journal:  J Immunol       Date:  1986-11-15       Impact factor: 5.422

7.  Inhibition of thyrotropin-stimulated adenosine 3',5'-monophosphate formation in rat thyroid cells by an adenosine analog. Evidence that the inhibition is mediated by the putative inhibitory guanine nucleotide regulatory protein.

Authors:  M I Berman; C G Thomas; S N Nayfeh
Journal:  J Cyclic Nucleotide Protein Phosphor Res       Date:  1986

8.  The release of neutrophil chemoattractant activity by bronchoalveolar macrophages from adult and senescent mice.

Authors:  A L Esposito; W J Poirier; C A Clark; M L Brown
Journal:  J Gerontol       Date:  1989-07

9.  Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells.

Authors:  B N Cronstein; R I Levin; J Belanoff; G Weissmann; R Hirschhorn
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

10.  Heterologous desensitization of the inhibitory A1 adenosine receptor-adenylate cyclase system in rat adipocytes. Regulation of both Ns and Ni.

Authors:  W J Parsons; G L Stiles
Journal:  J Biol Chem       Date:  1987-01-15       Impact factor: 5.157

View more
  114 in total

Review 1.  A(2A) adenosine receptors in human peripheral blood cells.

Authors:  S Gessi; K Varani; S Merighi; E Ongini; P A Borea
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

2.  Cyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A(2A) receptor agonists.

Authors:  G W Sullivan; J M Rieger; W M Scheld; T L Macdonald; J Linden
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

3.  E. coli lipopolysaccharide attenuates adenosine A(1) receptor-mediated increase in plasma exudation from the hamster cheek pouch.

Authors:  Xiao-pei Gao; Israel Rubinstein
Journal:  Inflamm Res       Date:  2010-10-06       Impact factor: 4.575

4.  Adenosine A2A receptor inactivation increases survival in polymicrobial sepsis.

Authors:  Zoltán H Németh; Balázs Csóka; Jeanette Wilmanski; Dazhong Xu; Qi Lu; Catherine Ledent; Edwin A Deitch; Pál Pacher; Zoltán Spolarics; György Haskó
Journal:  J Immunol       Date:  2006-05-01       Impact factor: 5.422

Review 5.  Ischemia and reperfusion--from mechanism to translation.

Authors:  Holger K Eltzschig; Tobias Eckle
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

6.  Purinergic regulation of bradykinin-induced plasma extravasation and adjuvant-induced arthritis in the rat.

Authors:  P G Green; A I Basbaum; C Helms; J D Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

7.  Chemical modification and irreversible inhibition of striatal A2a adenosine receptors.

Authors:  K A Jacobson; G L Stiles; X D Ji
Journal:  Mol Pharmacol       Date:  1992-07       Impact factor: 4.436

Review 8.  The inflammatory response to cell death.

Authors:  Kenneth L Rock; Hajime Kono
Journal:  Annu Rev Pathol       Date:  2008       Impact factor: 23.472

Review 9.  Adenosine receptors and asthma.

Authors:  R A Brown; D Spina; C P Page
Journal:  Br J Pharmacol       Date:  2008-03       Impact factor: 8.739

Review 10.  Adenosine receptors and asthma in humans.

Authors:  C N Wilson
Journal:  Br J Pharmacol       Date:  2008-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.